|
NAA20 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.382200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.123900E-03 |
| Normal-vs-Stage2 |
2.939400E-01 |
| Normal-vs-Stage3 |
1.869020E-01 |
| Normal-vs-Stage4 |
1.923160E-01 |
| Stage1-vs-Stage2 |
7.121200E-01 |
| Stage1-vs-Stage3 |
8.150200E-01 |
| Stage1-vs-Stage4 |
7.503400E-01 |
| Stage2-vs-Stage3 |
8.872800E-01 |
| Stage2-vs-Stage4 |
5.854800E-01 |
| Stage3-vs-Stage4 |
6.653800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.582300E-03 |
| Normal-vs-AfricanAmerican |
5.175400E-03 |
| Normal-vs-Asian |
9.270200E-01 |
| Caucasian-vs-AfricanAmerican |
3.975000E-01 |
| Caucasian-vs-Asian |
4.561200E-01 |
| AfricanAmerican-vs-Asian |
2.833000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.898000E-03 |
| Normal-vs-Female |
1.328130E-02 |
| Male-vs-Female |
5.926800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.668300E-02 |
| Normal-vs-Extreme_Weight |
2.355800E-02 |
| Normal-vs-Obese |
2.632300E-02 |
| Normal-vs-Extreme_Obese |
4.109800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.690000E-01 |
| Normal_Weight-vs-Obese |
8.564400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.739600E-01 |
| Extreme_Weight-vs-Obese |
7.948600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.531800E-01 |
| Obese-vs-Extreme_Obese |
9.450000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.184980E-01 |
| Normal-vs-Age(41-60Yrs) |
3.414800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.084820E-01 |
| Normal-vs-Age(81-100Yrs) |
9.322600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.707200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.698000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.823400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.898300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.125350E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.607000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.75919999999952E-05 |
| Normal-VS-Type2 PRCC |
3.772200E-01 |
| Normal-VS-KIRP CIMP |
2.706400E-01 |
| Normal-VS-Unclassified PRCC |
3.702200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.50700000000259E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.821600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.212200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.764200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.375660E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.899200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.819000E-01 |
| Normal-vs-N1 |
6.602300E-02 |
| Normal-vs-N2 |
2.392800E-01 |
| N0-vs-N1 |
4.936000E-01 |
| N0-vs-N2 |
3.693600E-01 |
| N1-vs-N2 |
1.471020E-01 |
|
|
